COVID-19 resources / Clinical Research Insights and News

The Cohortias Blog

Stay informed

COVID-19 resources

Cohortias is bringing clinical research to Latin America, now proud to participate in COVID-19 clinical trials.

Our archive includes insights from our experts as they discuss lessons learned over the past three months in managing COVID-19’s impact on trials in Latin America and around the world.

Our blog posts provide insights into what companies should be doing now to prepare for the upcoming ‘new normal’.


Venezuela to begin clinical trials of Cuba’s Abdala vaccine.

Venezuela this month will begin clinical trials of the Cuban coronavirus vaccine candidate Abdala.


Production of Sputnik V vaccine launched in Argentina.

Argentina was the first country in Latin America to officially register Sputnik V.


Brazil regulator rejects import of Russian vaccine.

Brazil’s National Health Regulation Agency (Anvisa) has declared itself against the import of the Russian Covid-19 vaccine Sputnik V.


Natco Pharma seeks approval of antiviral drug for COVID-19.

As per a press release from the Hyderabad-based company, pre-clinical data has proven that Molnupiravir has broad anti-influenza activity, comprising highly potent inhibition of SARS-CoV-2 replication.

COVID-19 Research - Free Consultation

The clinical development journey is fraught with pitfalls and roadblocks; COVID-19 has almost overnight added to the complexity. Innovations, technologies and reinvented processes can help. Our experienced team of experts shares experiences, lessons learned and tips to help you mitigate risk in the current environment while implementing some of the industry’s latest innovations.

covid clinical trials

The presence of clinical research in Latin America has been growing steadily for the last decade, mainly because of cost effectiveness, excellent patient recruitment and the emergence of FDA approved regulatory agencies.